Download PDF
Dtsch Med Wochenschr 2004; 129(7): 321-326
DOI: 10.1055/s-2004-818629
Übersichten
Kardiologie
© Georg Thieme Verlag Stuttgart · New York

Sind Antioxidantien zur Behandlung der Atherosklerose sinnvoll?

Is the supplementation with antioxidants effective in the treatment of atherosclerosis?St Schröder1
  • 1Medizinische Klinik, Abteilung für Kardiologie (Direktor: Prof. Dr. L. Seipel), Eberhard-Karls-Universität Tübingen
Further Information

Publication History

eingereicht: 9.7.2003

akzeptiert: 23.9.2003

Publication Date:
05 February 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Ergebnisse experimenteller und epidemiologischer Studien legen nahe, dass dem oxidativen Stress in der Entstehung und Progression der Atherosklerose im Menschen eine wichtige Bedeutung zukommt. Diese konnte in prospektiven Endpunktstudien bislang nicht nachgewiesen werden. In der vorliegenden Übersicht wird der aktuelle Stand der Literatur zusammenfasst.

Summary

Results from experimental and epidemiologic studies suggest an influence of oxidative stress on development and progression of atherosclerosis in man. Prospective endpoint studies failed to support this hypothesis. The current literature is summarized in this review.

Literatur

  • 1 Routine vitamin supplementation to prevent cancer and cardiovascular disease . Recommendations and rationale.  Ann Intern Med. 2003;  139 51-55
    Google Scholar
  • 2 Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A. et al . Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.  Lancet. 2000;  356 1213-1218
    Google Scholar
  • 3 Brasen J H, Koenig K, Bach H, Kontush A, Heinle H, Witting P K. et al . Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits.  Atherosclerosis. 2002;  163 249-259
    Google Scholar
  • 4 Brigelius-Flohe R, Kelly F J, Salonen J T, Neuzil J, Zingg J M, Azzi A. The European perspective on vitamin E: current knowledge and future research.  Am J Clin Nutr. 2002;  76 703-716
    Google Scholar
  • 5 Brown B G, Cheung M C, Lee A C, Zhao X Q, Chait A. Antioxidant vitamins and lipid therapy: end of a long romance?.  Arterioscler Thromb Vasc Biol. 2002;  22 1535-1546
    Google Scholar
  • 6 de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.  Lancet. 2001;  357 89-95
    Google Scholar
  • 7 de Lorgeril M, Salen P, Martin J L, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.  Circulation. 1999;  99 779-785
    Google Scholar
  • 8 Diaz M N, Frei B, Vita J A, Keaney J F. Antioxidants and atherosclerotic heart disease.  N Engl J Med. 1997;  337 408-416
    Google Scholar
  • 9 Drexler H. Endothelfunktion bei kardiovaskulären Erkrankungen. UNI-MED Verlag Bremen 2000
    Google Scholar
  • 10 Fayad Z A, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts.  Circulation. 2002;  106 2026-2034
    Google Scholar
  • 11 Frei B. To C or not to C, that is the question!.  J Am Coll Cardiol. 2003;  42 253-255
    Google Scholar
  • 12 Gaytan R J, Prisant L M. Oral nutritional supplements and heart disease: a review.  Am J Ther. 2001;  8 255-274
    Google Scholar
  • 13 GISSI-Study group . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico.  Lancet. 1999;  354 447-455
    Google Scholar
  • 14 Harris A, Devaraj S, Jialal I. Oxidative Stress, Alpha-tocopherol Therapy, and Atherosclerosis.  Curr Atheroscler Rep. 2002;  4 373-380
    Google Scholar
  • 15 Hein H O, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study.  BMJ. 1996;  312 736-741
    Google Scholar
  • 16 Heinecke J W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.  Arterioscler Thromb Vasc Biol. 2001;  21 1261-1264
    Google Scholar
  • 17 Heinecke J W. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis.  Am J Cardiol. 2003;  91 12A-16A
    Google Scholar
  • 18 Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.  Circulation. 2001;  104 2673-2678
    Google Scholar
  • 19 Hennekens C H, Buring J E, Manson J E, Stampfer M, Rosner B, Cook N R. et al . Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.  N Engl J Med. 1996;  334 1145-1149
    Google Scholar
  • 20 Hornig B. Vitamins, antioxidants and endothelial function in coronary artery disease.  Cardiovasc Drugs Ther. 2002;  16 401-409
    Google Scholar
  • 21 HPS-Study Group . MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.  Lancet. 2002;  360 23-33
    Google Scholar
  • 22 Jialal I, Devaraj S. Antioxidants and atherosclerosis: don’t throw out the baby with the bath water.  Circulation. 2003;  107 926-928
    Google Scholar
  • 23 Keaney J F, Vita J A. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action.  Prog Cardiovasc Dis. 1995;  38 129-154
    Google Scholar
  • 24 Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study.  BMJ. 1996;  312 478-481
    Google Scholar
  • 25 Libby P. Vascular biology of atherosclerosis: overview and state of the art.  Am J Cardiol. 2003;  91 3A-6A
    Google Scholar
  • 26 Littarru G P. Energie und Schutz. Casa Editrice Scientifica Internazionale, Rom 1994
    Google Scholar
  • 27 Morris C D, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force.  Ann Intern Med. 2003;  139 56-70
    Google Scholar
  • 28 Osganian S K, Stampfer M J, Rimm E, Spiegelman D, Hu F B, Manson J E. et al . Vitamin C and risk of coronary heart disease in women.  J Am Coll Cardiol. 2003;  42 246-252
    Google Scholar
  • 29 Rapola J M, Virtamo J, Ripatti S, Huttunen J K, Albanes D, Taylor P R. et al . Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.  Lancet. 1997;  349 1715-1720
    Google Scholar
  • 30 Rimm E B, Stampfer M J, Ascherio A, Giovannucci E, Colditz G A, Willett W C. Vitamin E consumption and the risk of coronary heart disease in men.  N Engl J Med. 1993;  328 1450-1456
    Google Scholar
  • 31 Salonen R M, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen T H. et al . Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study.  Circulation. 2003;  107 947-953
    Google Scholar
  • 32 Schroeder S, Kopp A F, Baumbach A, Meisner C, Kuettner A, Georg C. et al . Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography.  J Am Coll Cardiol. 2001;  37 1430-1435
    Google Scholar
  • 33 Stampfer M J, Hennekens C H, Manson J E, Colditz G A, Rosner B, Willett W C. Vitamin E consumption and the risk of coronary disease in women.  N Engl J Med. 1993;  328 1444-1449
    Google Scholar
  • 34 Steinberg D, Witztum J L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?.  Circulation. 2002;  105 2107-2111
    Google Scholar
  • 35 Stephens N G, Parsons A, Schofield P M, Kelly F, Cheeseman K, Mitchinson M J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS).  Lancet. 1996;  347 781-786
    Google Scholar
  • 36 Terentis A C, Thomas S R, Burr J A, Liebler D C, Stocker R. Vitamin E oxidation in human atherosclerotic lesions.  Circ Res. 2002;  90 333-339
    Google Scholar
  • 37 Thomas S R, Leichtweis S B, Pettersson K, Croft K D, Mori T A, Brown A J. et al . Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice.  Arterioscler Thromb Vasc Biol. 2001;  21 585-593
    Google Scholar
  • 38 U.S.Preventive Task Force . Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale.  Ann Intern Med. 2003;  139 51-55
    Google Scholar
  • 39 Virtamo J, Rapola J M, Ripatti S, Heinonen O P, Taylor P R, Albanes D. et al . Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease.  Arch Intern Med. 1998;  158 668-675
    Google Scholar
  • 40 Wasserman M A, Sundell C L, Kunsch C, Edwards D, Meng C Q, Medford R M. Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease.  Am J Cardiol. 2003;  91 34A-40A
    Google Scholar
  • 41 Willett W C, Stampfer M J. Clinical practice. What vitamins should I be taking, doctor?.  N Engl J Med. 2001;  345 1819-1824
    Google Scholar
  • 42 Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.  N Engl J Med. 2000;  342 154-160
    Google Scholar

Priv.-Doz. Dr. Stephen Schröder

Medizinische Klinik Tübingen, Abteilung für Kardiologie

Otfried-Müller-Straße 10

72076 Tübingen

Phone: 07071/2982711

Fax: 07121/478962

Email: Stephen.Schroeder@med.uni-tuebingen.de

      >